Cohen Milstein Sellers & Toll PLLC's Sharon K. Robertson has helped plaintiffs score big wins in antitrust cases accusing pharmaceutical companies of not playing by the rules, including a nearly $104.8 million settlement for Lidoderm end-payors in a suit alleging a pay-for-delay scheme, landing her among Law360's 2019 Life Sciences MVPs.
Her biggest accomplishments from the past year:
Robertson helped secure final approval for a nearly $104.8 million settlement agreement for a class of end-payors in litigation over an alleged $266 million deal to stymie a generic version of the blockbuster anesthetic Lidoderm.
Leading up to the September 2018 deal, Robertson and her team employed experts and secured third-party discovery to counter the idea that it wasn't possible to obtain or use the data necessary for identifying class members.
"In fighting against that, we really took a novel approach of utilizing third-party discovery and our own experts to combat that notion, and I think it was persuasive and the court certified our class and we've had a number of additional victories throughout the case," she said.
Ms. Robertson’s complete MVP profile can be viewed here.